
News • New study
AI better at spotting heart failure than current tests
Artificial intelligence can help diagnose acute heart failure with more accuracy than current blood tests alone, research suggests.
Artificial intelligence can help diagnose acute heart failure with more accuracy than current blood tests alone, research suggests.
Recovery from severe Covid-19 is characterized by a reduction of certain white blood cells and changes in the molecular regulation of the immune system, an international research team found.
A new AI platform can analyze genomic data extremely quickly, picking out key patterns to classify different types of colorectal tumors and improve the drug discovery process.
Around one in 500 men could be carrying an extra X or Y chromosome – most of them unaware – putting them at increased risk of diseases such as type 2 diabetes, atherosclerosis and thrombosis.
Individuals with diabetes display a substantially increased risk of disease in left-sided heart valves compared to controls without diabetes, a new comprehensive register study shows.
Changes in areas of the brain associated with emotion have been identified in people with Takotsubo syndrome, sometimes known as broken heart syndrome, according to new research.
Researchers have developed a biodegradable gel that can help to improve the delivery of cells into the living heart and could form a new generation of treatments to repair heart attack damage.
Clear ethical standards and guidance are needed for AI in health settings to protect the relationship of trust between doctors and patients and to safeguard human rights, according to a new report.
A research group from Kyoto developed two in vitro models to study SARS-CoV-2, and showed that they can be used for drug screening for infectious diseases including Covid-19.
Researchers have shown that aggregation of amyloid-beta, one of two key proteins implicated in Alzheimer’s disease, causes cells to overheat and ‘fry like eggs.’
A simple blood test could be a better predictor of whether cancer immunotherapy will be successful for a patient with lung cancer than an invasive tumor biopsy procedure.
Over the last 50 years, malaria parasites have developed resistance to seven drugs, but a new way to identify future antimalarials holds promise.
Researchers have developed 3D printed artificial heart valves designed to allow a patient’s own cells to form new tissue.
Newly engineered in vitro tumour models open ways to better understand the crosstalk between liver cancer cells and their microenvironment, researchers from Singapore found.
Latest developments in computational protein design enable the simulation of sequence and structural changes in proteins for creating novel agents in human medicine.
When a virus makes its way into the body, one of the immune system’s first responders is a set of pathogen-removal cells called macrophages. But they don’t all target viruses in the same way.
Hospital-acquired infections are dangerous for patients and costly for clinics. A novel surface treatment could help improve the safety of medical devices and ease the economic burden.
Glucose is absorbed from the foods we eat and fuels every cell in our bodies. But could it also power tomorrow’s medical implants? According to a team of engineers, it might.
In patients with serious and long-term Covid-19, disturbed blood coagulation is often observed. Now, Swedish researchers found a connection between harmful amyloid production and Covid-19 symptoms.
Bacteriophages – viruses that kill bacteria – could be a solution for fighting antibiotic-resistant pathogens, French researchers have developed a model to better predict their efficacy.
A research team in Spain and the US has created 3D-printed acoustic holograms to improve the treatment of diseases like Alzheimer's and Parkinson's, among others.
Ultra-powerful 7T MRI scanners could be used to help identify patients with Parkinson’s disease and similar conditions who are most likely to benefit from new treatments, say scientists.
The path from evidence-based research to clinical implementation is straightforward in theory but taxing in practice: Research groups must be coordinated, relevant published material identified, classified, and prepared, to shape findings into a comprehensive SOP for clinical use. To facilitate this complex process, Wolters Kluwer developed a new suite of applications, called Ovid Synthesis.
Scientists from France and Belgium gained insights into the structure and function of a central liver protein: NTCP, a cellular-entry pathway for bile salts – but also for certain hepatitis viruses.
Swiss researchers discovered how different cell types in cortex change their activity during general anesthesia, helping to understand how unconsciousness may be induced.